Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Karim Seif El Dahan, Darine Daher, Amit G. Singal

Clin Mol Hepatol. 2023;29(Suppl):S207-S219. Published online September 14, 2022

DOI: https://doi.org/10.3350/cmh.2022.0247

View: 3741 Download: 92 Citation: 1

Ibrahim A. Hanouneh, Naim Alkhouri, Amit G. Singal

Clin Mol Hepatol. 2019;25(3):264-269. Published online March 4, 2019

DOI: https://doi.org/10.3350/cmh.2019.1001

View: 7842 Download: 308 Citations: 40

Yi-Te Lee, Mohammad Karim, Hye Chung Kum, Sulki Park, Nicole E. Rich, Mazen Noureddin, Amit G. Singal, Ju Dong Yang

Received December 15, 2022 Accepted January 29, 2023

DOI: https://doi.org/10.3350/cmh.2022.0450 [Accepted]

View: 393 Download: 35

1 |

Viewed By 5609	Subclinical versus advanced forms of alcohol-related liver disease: Need for early detection
Viewed By 3575	Hepatocellular carcinoma surveillance in patients with non-alcoholic fatty liver disease
Viewed By 3247	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Viewed By 2699	Pathogenesis and treatment of non-alcoholic steatohepatitis and its fibrosis
Viewed By 2606	The emerging roles of extracellular vesicles as intercellular messengers in liver physiology and pathology

Cited By 88	KASL clinical practice guidelines: Management of nonalcoholic fatty liver disease
Cited By 40	From nonalcoholic fatty liver disease to metabolic-associated fatty liver disease: Big wave or ripple?
Cited By 36	Lactobacillus attenuates progression of nonalcoholic fatty liver disease by lowering cholesterol and steatosis
Cited By 34	Obesity and the risk of primary liver cancer: A systematic review and meta-analysis
Cited By 33	The development of mesenchymal stem cell therapy in the present, and the perspective of cell-free therapy in the future

Search